Skip to main content

Site notifications

DALACIN C clindamycin 600mg/4mL (as phosphate) injection ampoule, Pfizer Australia Pty Ltd, CON-1252

Product name
DALACIN C clindamycin 600mg/4mL (as phosphate) injection ampoule
Sponsor name
Pfizer Australia Pty Ltd
Consent start
Consent no.
CON-1252
Duration
The consent is effective from 3 July 2024 until 30 September 2026.
Standard
Paragraphs 8(1)(f), 8(1)(g), 10(4)(h) and 10(4)(i) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product labels (carton and ampoule) do not have batch number and expiry date prefixes immediately preceding the batch number and expiry date.
Import, Supply, &/or Export
import and supply
Therapeutic product type
Prescription medicines

Help us improve the Therapeutic Goods Administration site